![]() |
| JustRight 5 mm surgical stapler--Courtesy JustRight |
JustRight Surgical, the developer of tissue-sealing devices, raised $7.5 million in funding it will use to begin a marketing and sales push for its new surgical stapler.
Investors were not named in the SEC filing, though co-founder and CEO Russ Lindemann told the Boulder County Business Report it was the same group of local investors who participated in previous funding. Founded in 2010, JustRight has raised of total of $22.5 million in venture capital. Lindemann declined to disclose company revenues.
The Boulder, CO-based company received FDA approval in February for its 5 mm stapler, just months after getting the nod from the government agency to sell its 3 mm vessel sealing system.
Originally founded under the name Innovative Pediatric Devices, JustRight develops surgical sealing instruments it touts as being able to allow access to confined and delicate structures in the human body, and that make smaller incisions resulting in less scarring and shorter healing time. The devices are popular with pediatric surgeons, whose work is defined by confined spaces and limited maneuverability.
The company hopes to have several more of its products entering the FDA approval process by the end of the year.
- see the SEC filing
- read the Boulder County Business Report story
